test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLSApellis Pharmaceuticals Inc
Recent Activity
Increased 2.45%
11.74%
$342.932M
11.891M shares@ $28.84 avg price
ANABAnaptysbio Inc
Recent Activity
Increased 3.65%
8.94%
$261.132M
7.795M shares@ $33.5 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
Increased 3.2%
7.51%
$219.123M
4.288M shares@ $51.1 avg price
PRTAProthena Corp Plc
Recent Activity
6.64%
$193.805M
11.584M shares@ $16.73 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
Increased 68.3%
6.51%
$190.118M
1.706M shares@ $111.41 avg price
ZYMEZymeworks Inc
Recent Activity
5.78%
$168.64M
13.437M shares@ $12.55 avg price
ARVNArvinas Inc
Recent Activity
5.68%
$165.673M
6.726M shares@ $24.63 avg price
KURAKura Oncology Inc
Recent Activity
3.89%
$113.466M
5.807M shares@ $19.54 avg price
XNCRXencor Inc
Recent Activity
3.67%
$107.195M
5.33M shares@ $20.12 avg price
TNGXTango Therapeutics Inc
Recent Activity
3.52%
$102.647M
13.331M shares@ $7.7 avg price